Immuneel Therapeutics Raises INR 100 Cr to Expand Cancer Therapy Innovations As part of the deal, the Bengaluru-based firm providing cancer therapy will distribute up to 8,164 Series A2 Compulsorily Convertible Preference shares and 10 equity shares.

By Entrepreneur Staff

You're reading Entrepreneur India, an international franchise of Entrepreneur Media.

Freepik

Cancer focused biotech startup Immuneel Therapeutics has announced the raising of INR 100 crore from TAIBA Middle East FZ LLC.

The company has raised over USD 40 million so far, which includes the USD 15 million Series A investment that it received in 2022 from True North, Eight Roads Ventures, and F-Prime Capital.

Immuneel Therapeutic's board has approved a special resolution to issue 8,164 Series A1 CCPS and 10 equity shares at a price of INR 1,22,330 each in order to fund USD 12 million, or INR 100 crore, according to the company's regulatory filing accessed from the Registrar of Companies show.

The company intends to utilise these investments for growth and expansion, in accordance with board decisions.

Founded by Biocon founder Kiran Mazumdar Shaw, oncologist and Pulitzer winner Siddhartha Mukherjee and Kush Parwar, Immuneel Therapeutics is an Indian clinical-stage startup which is engaged in developing cell and gene therapies for cancer patients.

In addition, it is creating its own pipeline of cellular immunotherapies and chimeric antigen receptor T-cell (CAR-T) therapies for cancer therapy and management. According to the company, medicines are available for one-third of what gene therapies in America cost.

Entrepreneur Staff

Entrepreneur Staff

Editor

For more than 30 years, Entrepreneur has set the course for success for millions of entrepreneurs and small business owners. We'll teach you the secrets of the winners and give you exactly what you need to lay the groundwork for success.
Business Ideas

70 Small Business Ideas to Start in 2025

We put together a list of the best, most profitable small business ideas for entrepreneurs to pursue in 2025.

Growing a Business

'Boring' Businesses Are Making Millionaires — and You Can Borrow Their Strategies For Success

The silent growth strategy reveals how understated, steady businesses are quietly creating wealth for entrepreneurs in 2025. By focusing on long-term consistency and incremental progress, these "boring" industries are proving to be gold mines for those willing to embrace stability over hype.

News and Trends

Temasek Acquires 10% Stake in Haldiram's for $1 Billion

The transaction marks one of the largest foreign investments in India's food sector, highlighting the growing appeal of the country's consumer market to global investors.

News and Trends

Zoho Introduces Projects Plus, an AI-Powered Project Management Platform for Enterprises

The platform supports asynchronous collaboration, file management, business intelligence, and hybrid project management methodologies, catering to the evolving demands of enterprises

Starting a Business

How This Raw Food Startup Is Taking a Bite Out of the $45B Pet Industry

We Feed Raw wants to change your dog's diet to how it was meant to be.

News and Trends

Zolve Secures USD 251M in Series B Funding to Expand Cross-Border Financial Services

Since its launch in 2021, Zolve has witnessed rapid growth, becoming customer-level profitable in early 2024 and aiming for company-level profitability by the end of 2025